133 related articles for article (PubMed ID: 29031543)
1. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
Gu YH; Feng YG
J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
[TBL] [Abstract][Full Text] [Related]
2. The expression of TGF-β1, Smad3, phospho-Smad3 and Smad7 is correlated with the development and invasion of nonfunctioning pituitary adenomas.
Zhenye L; Chuzhong L; Youtu W; Xiaolei L; Lei C; Lichuan H; Hongyun W; Yonggang W; Fei W; Yazhuo Z
J Transl Med; 2014 Mar; 12():71. PubMed ID: 24636138
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas.
Kim YH; Kim JH
Endocrinol Metab (Seoul); 2019 Sep; 34(3):314-322. PubMed ID: 31565884
[TBL] [Abstract][Full Text] [Related]
5. Integrative proteomics and transcriptomics identify novel invasive-related biomarkers of non-functioning pituitary adenomas.
Yu SY; Hong LC; Feng J; Wu YT; Zhang YZ
Tumour Biol; 2016 Jul; 37(7):8923-30. PubMed ID: 26753958
[TBL] [Abstract][Full Text] [Related]
6. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
[TBL] [Abstract][Full Text] [Related]
7. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
[TBL] [Abstract][Full Text] [Related]
10. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
[TBL] [Abstract][Full Text] [Related]
11. MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes.
Uraki S; Ariyasu H; Doi A; Takeshima K; Morita S; Inaba H; Furuta H; Fukuhara N; Inoshita N; Nishioka H; Nakao N; Yamada S; Akamizu T
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325698
[TBL] [Abstract][Full Text] [Related]
12. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of the sFRP and WIF1 genes in invasive non-functioning pituitary adenomas.
Song W; Qian L; Jing G; Jie F; Xiaosong S; Chunhui L; Yangfang L; Guilin L; Gao H; Yazhuo Z
Mol Cell Endocrinol; 2018 Oct; 474():168-175. PubMed ID: 29555596
[TBL] [Abstract][Full Text] [Related]
14. Alterations in CD8
Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
[TBL] [Abstract][Full Text] [Related]
15. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry.
Hattori Y; Ishii H; Tahara S; Morita A; Ozawa H
Life Sci; 2020 Nov; 260():118416. PubMed ID: 32926922
[TBL] [Abstract][Full Text] [Related]
16. Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas.
Liu C; Li Z; Wu D; Li C; Zhang Y
Onco Targets Ther; 2016; 9():2265-71. PubMed ID: 27143922
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific expression and alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-beta receptors in human pituitary adenomas.
Alexander JM; Bikkal HA; Zervas NT; Laws ER; Klibanski A
J Clin Endocrinol Metab; 1996 Feb; 81(2):783-90. PubMed ID: 8636304
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Invasive Nonfunctional Pituitary Adenomas by Serum Extracellular Vesicles.
Wang H; Chen K; Yang Z; Li W; Wang C; Zhang G; Zhu L; Liu P; Yang Y
Anal Chem; 2019 Aug; 91(15):9580-9589. PubMed ID: 31264409
[TBL] [Abstract][Full Text] [Related]
19. circOMA1-Mediated miR-145-5p Suppresses Tumor Growth of Nonfunctioning Pituitary Adenomas by Targeting TPT1.
Du Q; Hu B; Feng Y; Wang Z; Wang X; Zhu D; Zhu Y; Jiang X; Wang H
J Clin Endocrinol Metab; 2019 Jun; 104(6):2419-2434. PubMed ID: 30721952
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
